I've never been this patient with any investment. Aside from the management team, BOD, BOA, pipeline and tremendous potential to help millions of patients, I keep telling myself Amgen was trading at $0.09 in September 1984. At that time, it was roughly 5 years from getting its first product approved by the FDA.
Now I'm not saying AMBS will become another Amgen. Only time will tell. But what I tell myself is that good (and sometimes great) things come to those who are patient.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links